Literature DB >> 29627106

Clinical Features Associated With Nascent Left Ventricular Diastolic Dysfunction in a Population Aged 40 to 55 Years.

Jonathan D Mosley1, Rebecca T Levinson2, Evan L Brittain2, Deepak K Gupta2, Eric Farber-Eger2, Christian M Shaffer3, Josh C Denny2, Dan M Roden4, Quinn S Wells5.   

Abstract

Diastolic dysfunction (DD), an abnormality in cardiac left ventricular (LV) chamber compliance, is associated with increased morbidity and mortality. Although DD has been extensively studied in older populations, co-morbidity patterns are less well characterized in middle-aged subjects. We screened 156,434 subjects with transthoracic echocardiogram reports available through Vanderbilt's electronic heath record and identified 6,612 subjects 40 to 55 years old with an LV ejection fraction ≥50% and diastolic function staging. We tested 452 incident and prevalent clinical diagnoses for associations with early-stage DD (n = 1,676) versus normal function. There were 44 co-morbid diagnoses associated with grade 1 DD including hypertension (odds ratio [OR] = 2.02, 95% confidence interval [CI] 1.78 to 2.28, p <5.3 × 10-29), type 2 diabetes (OR 1.96, 95% CI 1.68 to 2.29, p = 2.1 × 10-17), tachycardia (OR 1.38, 95% CI 0.53 to 2.19, p = 2.9 × 10-6), obesity (OR 1.76, 95% CI 1.51 to 2.06, p = 1.7 × 10-12), and clinical end points, including end-stage renal disease (OR 3.29, 95% CI 2.19 to 4.96, p = 1.2 × 10-8) and stroke (OR 1.5, 95% CI 1.12 to 2.02, p = 6.9 × 10-3). Among the 60 incident diagnoses associated with DD, heart failure with preserved ejection fraction (OR 4.63, 95% CI 3.39 to 6.32, p = 6.3 × 10-22) had the most significant association. Among subjects with normal diastolic function and blood pressure at baseline, a blood pressure measurement in the hypertensive range at the time of the second echocardiogram was associated with progression to stage 1 DD (p = 0.04). In conclusion, DD was common among subjects 40 to 55 years old and was associated with a heavy burden of co-morbid disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29627106      PMCID: PMC5975107          DOI: 10.1016/j.amjcard.2018.02.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

Review 1.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

2.  Progression of preclinical diastolic dysfunction to the development of symptoms.

Authors:  Daniel D Correa de Sa; David O Hodge; Joshua P Slusser; Magaret M Redfield; Robert D Simari; John C Burnett; Horng H Chen
Journal:  Heart       Date:  2010-04       Impact factor: 5.994

3.  Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction.

Authors:  Wael Aljaroudi; M Chadi Alraies; Carmel Halley; Leonardo Rodriguez; Richard A Grimm; James D Thomas; Wael A Jaber
Journal:  Circulation       Date:  2012-01-18       Impact factor: 29.690

Review 4.  Diastolic dysfunction.

Authors:  Euy-Myoung Jeong; Samuel C Dudley
Journal:  Circ J       Date:  2015-02-05       Impact factor: 2.993

5.  Progression of left ventricular diastolic dysfunction and risk of heart failure.

Authors:  Garvan C Kane; Barry L Karon; Douglas W Mahoney; Margaret M Redfield; Veronique L Roger; John C Burnett; Steven J Jacobsen; Richard J Rodeheffer
Journal:  JAMA       Date:  2011-08-24       Impact factor: 56.272

6.  Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan.

Authors:  A V Mattioli; M Zennaro; S Bonatti; L Bonetti; G Mattioli
Journal:  Int J Cardiol       Date:  2004-12       Impact factor: 4.164

7.  PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations.

Authors:  Joshua C Denny; Marylyn D Ritchie; Melissa A Basford; Jill M Pulley; Lisa Bastarache; Kristin Brown-Gentry; Deede Wang; Dan R Masys; Dan M Roden; Dana C Crawford
Journal:  Bioinformatics       Date:  2010-03-24       Impact factor: 6.937

8.  Prevalence, prospective risk markers, and prognosis associated with the presence of left ventricular diastolic dysfunction in young adults: the coronary artery risk development in young adults study.

Authors:  Chintan S Desai; Laura A Colangelo; Kiang Liu; David R Jacobs; Nakela L Cook; Donald M Lloyd-Jones; Kofo O Ogunyankin
Journal:  Am J Epidemiol       Date:  2012-12-04       Impact factor: 4.897

9.  Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey.

Authors:  W P Abhayaratna; T H Marwick; W T Smith; N G Becker
Journal:  Heart       Date:  2006-02-17       Impact factor: 5.994

10.  Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease.

Authors:  Xiushui Ren; Bryan Ristow; Beeya Na; Sadia Ali; Nelson B Schiller; Mary A Whooley
Journal:  Am J Cardiol       Date:  2007-04-27       Impact factor: 2.778

View more
  4 in total

1.  Genetic Determinants of Body Mass Index and Fasting Glucose Are Mediators of Grade 1 Diastolic Dysfunction.

Authors:  Nataraja Sarma Vaitinadin; Mingjian Shi; Christian M Shaffer; Eric Farber-Eger; Brandon D Lowery; Vineet Agrawal; Deepak K Gupta; Dan M Roden; Quinn S Wells; Jonathan D Mosley
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

Review 2.  The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.

Authors:  Giacomo Zoppini; Corinna Bergamini; Alessandro Mantovani; Marco Dauriz; Giovanni Targher; Andrea Rossi; Enzo Bonora
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

3.  Heart failure clinical care analysis uncovers risk reduction opportunities for preserved ejection fraction subtype.

Authors:  Rebecca T Levinson; Nataraja Sarma Vaitinidin; Quinn S Wells; Jonathan D Mosley; Eric Farber-Eger; Dan M Roden; Thomas A Lasko
Journal:  Sci Rep       Date:  2021-09-20       Impact factor: 4.379

4.  Characterisation of aortic stenosis severity: a retrospective analysis of echocardiography reports in a clinical laboratory.

Authors:  Michael A Raddatz; Holly M Gonzales; Eric Farber-Eger; Quinn S Wells; Brian R Lindman; W David Merryman
Journal:  Open Heart       Date:  2020-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.